Home
Conditions
Neurodegenerative Diseases

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,004 public trials 1,759 recruiting studies

Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

NCT01266525

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Investigational Site Number 840041 Gilbert, Arizona, United States

Investigational Site Number 840032 Phoenix, Arizona, United States

Investigational Site Number 840024 Costa Mesa, California, United States

Investigational Site Number 840013 Fresno, California, United States

View all 82 locations

View Trial Details

Completed

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

NCT01325571

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Beijing, China

Guangdong, China

Jiangsu, China

Jilin City, China

View Trial Details

Completed

Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)

NCT01303406

Conditions: Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +12 more
Locations: Innsbruck, Austria

Bonn, Germany

München, Germany

Tübingen, Germany

View Trial Details

Completed

Behavior Addictions Improvement in Parkinson Disease's Patients Treated by Subthalamic Stimulation : Long Term Follow-up

NCT01705418

Conditions: Basal Ganglia Diseases, Behavior, Brain Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Autologous Peripheral Nerve Grafts Into the Substantia Nigra of Subjects With PD Undergoing Deep Brain Stimulation

NCT01833364

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: University of Kentucky Medical Center Lexington, Kentucky, United States

University of Kentucky Medical Center Lexington, Kentucky, United States

View Trial Details

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers

NCT02111330

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: CIM Sant Pau - I.I.B. Sant Pau Barcelona, Spain

Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain

View Trial Details

Completed

Alzheimer's Disease Multiple Intervention Trial

NCT01314950

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Wishard Health Services Indianapolis, Indiana, United States

View Trial Details

Completed

Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers

NCT02208934

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: CIM-Sant Pau - IIB Sant Pau, HSCSP Barcelona, Spain

Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain

View Trial Details

Completed

Aquatic Therapy Versus Land-Based Therapy for the Treatment of Balance Dysfunction in Parkinson's Disease

NCT02701621

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Department of Parkinson's Disease and Brain Injury Rehabilitation, of the 'Moriggia-Pelascini' Hospital Gravedona Ed Uniti, Como, Italy

View Trial Details

Completed

Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers

NCT01691924

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain

Cim- Sant Pau, HSCSP Barcelona, Catalunya/Barcelona, Spain

View Trial Details

Neurodegenerative Diseases

Neurodegenerative Diseases trial results

Related conditions